Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T16973 |
TAK-220
|
HIV Protease | Microbiology/Virology; Proteases/Proteasome |
TAK-220 is a selective and orally bioavailable CCR5 antagonist (IC50s: 3.5 nM and 1.4 nM for inhibition on the binding of RANTES and MIP-1α to CCR5, respectively). | |||
T68892 | TAK-220 Hydrochloride | ||
TAK-220 hydrochloride is an anti-HIV CCR5 antagonist. |